Cytodyn Inc (CYDY)

[DonDonDonDon]

This is a protocol for severe covid with lenzilumab , if you compare to our moderate protocol is the same except they excluding all patients with any secondary infections

Imitation is the sincerest form of flattery. Lenzilumab had awesome success with newly hospitalized patients. With early and mid stage severe patients under 85yo, it had 296% efficacy on preventing mechanical ventilation and 217% efficacy on preventing mortality.

Treating a newly hospitalized patient is the perfect time to use an immunomodulator. Stop the cytokine storm when it is starting. There is little difference between a late stage moderate who is newly hospitalized and an early stage severe who is newly hospitalized. CytoDyn saw lenzilumab's amazing success and they copied it. Smart move by CytoDyn.

While HGEN and CYDY are now in direct competition, lenzilumab is at least a year ahead of leronlimab in timeline. Also, lenzilumab targets GM-CSF which has been proven to be the key to Covid.

https://www.bbc.com/news/health-56352128